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Abstract This study aimed to comparatively evaluate the in
vitro effect of nanosized hydroxyapatite and collagen (nHA/
COL) based composite hydrogels (with different ratios of
nHA and COL) on the behavior of human mesenchymal stro-
mal cells (MSCs), isolated from either adipose tissue (AT-
MSCs) or bone marrow (BM-MSCs). We hypothesized that
(i) nHA/COL composite hydrogels would promote the osteo-
genic differentiation ofMSCs in an nHA concentration depen-
dent manner, and that (ii) AT-MSCs would show higher oste-
ogenic potential compared to BM-MSCs, due to their earlier
observed higher proliferation and osteogenic differentiation
potential in 2D in vitro cultures [1]. The obtained results indi-
cated that AT-MSCs show indeed high proliferation, differen-
tiation and mineralization capacities in nHA/COL constructs
compared to BM-MSCs, but this effect was irrespective of
nHA concentration. Based on the results of alkaline phospha-
tase (ALP) activity and osteocalcin (OCN) protein level, the
osteogenic differentiation of BM-MSCs started in the begin-
ning of the culture period and for AT-MSCs at the end of the
culture period. At a molecular level, both cell types showed
high expression of osteogenic markers (bone morphogenic
protein 2 [BMP2], runt-related transcription factor 2
[RUNX2], OCN or COL1) in both an nHA concentration
and time dependent manner. In conclusion, AT-MSCs demon-
strated higher osteogenic potential in nHA/COL based 3D
micro-environments compared to BM-MSCs, in which prolif-
eration and osteogenic differentiation were highly promoted
in a time dependent manner, irrespective of nHA amount in
the constructs. The fact that AT-MSCs showed high prolifer-
ation and mineralization potential is appealing for their appli-
cation in future pre-clinical research as an alternative cell
source for BM-MSCs.
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Introduction
Bone loss, caused by trauma, tumor resection or congenital
disorders, is an increasingly serious health problem, for which
current treatment remains a clinical challenge, especially for
critical size bone defects [2]. Structurally, bone tissue forms
the human skeleton, which consists of multiple cell types and
a largely mineralized extracellular matrix (ECM). The organic
part of ECM is composed of protein fibers (mainly type 1
collagen), which represents about 30 wt% of bone. The inor-
ganic part of bone is composed of minerals (~70 wt% of
bone), with hydroxyapatite (HA; Ca10(PO4)6(OH)2) as the
major component [3, 4]. As such, the weight ratio between
collagen and HA is approximately 1:2. These HA crystals,
embeddedwithin the extracellular matrix, are very small, mea-
suring approximately 200 Å (in the largest dimension, i.e.
nano-sized HA, nHA) [5]. In a synergistic manner, the strands
of collagen provide bone with tensile strength and the inter-
spersed nHA crystals provide compressional strength [5].
Nowadays in bone regenerative research, the use of scaf-
fold systems receives remarkable attention, because of the
increasing demand to replace autologous bone for grafting
purposes. For an appropriate cell attachment, proliferation
and osteogenic differentiation, scaffolds need to meet several
requirements, e.g. biocompatibility, ability of fluid transport,
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delivery of bioactive molecules, surface topographical cues,
degradability and ability to induce signal transduction [6].
In view of biomimicry, it seems appealing to develop scaf-
folds that combine structural properties of bone ECM. Among
the different materials available for scaffold preparation,
hydrogels represent a highly versatile group of biomaterials
with appealing properties for 3D scaffolding. Hydrogels are
hydrophilic networks (water content ⩾ 30 % by weight) of
natural or synthetic polymer chains, which approximate the
viscoelastic properties of native tissue [7]. Because of distinc-
tive features, such as biocompatibility, cell-controlled degrad-
ability, injectability and ability to release drugs or bioactive
molecules, hydrogels are considered as reliable biomaterials
for the regeneration of a wide range of tissues, including car-
tilage and bone [6, 8]. The advantages of natural hydrogels
(i.e. collagen, fibrin) include among others their non antigenic
and intrinsic cellular interaction capacities [9]. Moreover, col-
lagen based hydrogels support the expression of an osteogenic
phenotype of (differentiating) MSCs in vivo [10]. However,
the mechanical properties of collagen are relatively low
(E ~ 100 MPa) in comparison to bone (E ~ 2-50GPa) [11].
To obtain more biomimetic scaffold systems for bone regen-
eration, several attempts have focused on the combination of a
hydrogel and HA to study effects of cell behavior (mainly
mesenchymal stromal cells, MSCs) in vitro and bone regen-
eration in vivo [12–14]. These studies have shown that HA/
collagen based composite hydrogels can have potential to en-
hance MSC osteogenic differentiation [8, 15].
From a cellular perspective, hydrogels provide a 3Dmicro-
environment to which cells can attach, attain a specific mor-
phology, have 3D cell-cell/cell-biomaterial interactions and
subsequently proliferate and differentiate [16]. Moreover, for
bone regeneration, the use of cell-based constructs provides
osteoinductive properties [17, 18] in comparison to bare scaf-
folds [19, 20]. Since in the developmental and regenerative
processes of bone BM-MSCs are involved, they have become
the main cell source for bone tissue engineering [21]. Howev-
er, MSCs can be extracted from different tissues, such as skin,
muscle, periodontal ligament, blood, adipose tissue (AT) and
the yield of extracted cells is dependent of cell source. The
easiest harvesting of MSCs (less invasive) with substantial
yield is from adipose tissue [1, 22]. Moreover, at the same
2D culture condition (using platelet lysate [PL] or fetal bovine
serum [FBS] as nutritional supplement), AT-MSCs showed
higher proliferation and osteogenic differentiation capacities
compared to BM-MSCs, and AT-MCSs showed their highest
proliferation and osteogenic differentiation capacities in PL
supplemented media, whereas BM-MSCs did in FBS supple-
mented media [1, 23]. In view of this, the major challenge
remains to understand the complexity of cellular responses
of different MSCs to different scaffold systems.
The aim of this study was to comparatively evaluate the in
vitro effect of biomimetic nHA/collagen based composite
hydrogels (with different ratios of nHA) on the behavior of
human MSCs, isolated from adipose tissue (AT-MSCs) or
bone marrow (BM-MSCs). We hypothesized that (i) nHA/
collagen based hydrogels will promote the osteogenic differ-
entiation of MSCs in an nHA concentration dependent man-
ner, (ii) AT-MSCs will show higher osteogenic potential com-
pared to BM-MSCs, because of their intrinsic higher prolifer-
ation and osteogenic differentiation potential in 2D in vitro
cultures.
Materials and Methods
Cell Culture
AT-MSCs were isolated from fat tissue of healthy human do-
nors. The fat tissue was obtained from the Department of
Plastic Surgery (Radboudumc, The Netherlands) after written
informed consent. BM-MSCs were isolated from human iliac
bone chips, obtained from patients undergoing maxillofacial
surgery at the Department of Oral and Craniofacial Surgery
(Radboudumc, The Netherlands) after written informed con-
sent. MSC extraction was performed according to the princi-
ples of the Declaration of Helsinki. The isolation procedure of
AT-MSCs and BM-MSCs is described in detail elsewhere [1,
24–26]. Harvested cells were examined by fluorescence-
activated cell sorting (FACS) for positive expression of
CD73, CD90 and CD105 (eBioscience, San Diego, USA)
and negative expression of CD45 (R&D system, Abingdon,
United Kingdom). Next, both cell types were examined (via
biochemical assays) for their osteogenic potential, i.e. ALP
activity and calcium deposition.
Upon usage, MSCs were cultured in corresponding prolif-
eration media consisting of alpha Minimal Essential Medium,
(α-MEM; Gibco®, Life Technologies, Grand Island, USA)
supplemented either with 5 % PL (Sanquin Blood Bank,
The Netherlands) for AT-MSCs or with 15 % fetal bovine
serum (FBS; Lonza, Basel, Switzerland) for BM-MSCs [1],
at 37°C in humid atmosphere with 5 % CO2 (the complete
composition of proliferation media is given in Table 1). Me-
dium was changed twice a week. Cells were passaged upon
reaching ~80 % confluency using 0.25%w/v trypsin/0.02 %
EDTA (Gibco®).
Preparation of Hydrogels and Experimental Groups
Prior to the preparation of hydrogel scaffolds, nHA crystals
(size: 20–500 nm; Berkeley Advanced Biomaterials, Berke-
ley, CA, USA) were suspended in PBS (10× concentrated) at a
final concentration of 150 mg/ml. The suspension was ho-
mogenized by sonication for 20 min. Before addition to
hydrogels (see Table 2), this suspension was vortexed for
1 min. For the preparation of hydrogels, collagen type 1
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(COL; rat tail; BD Bioscience, Bedford MA, USA) was used
with various amounts of nHA (Table 2). The procedure of
hydrogel preparation was according to the manufacturer’s in-
struction (Table 2), and composite nHA/COL hydrogels were
prepared with an nHA/COL ratio (wt/wt) of 0/1, 1/1, and 2/1.
MSCs were added during hydrogel preparation (Table 2). Cell
seeding density of AT-MSCs and BM-MSCs in all experimen-
tal groups was 1x106 per 1 ml of hydrogels (Table 3).
Table 1 Composition of the
proliferation media (PM) and os-
teogenic media (OM)
BM-MSCs AT-MSCs
Minimal Essential Medium (α-MEM) Minimal Essential Medium (α-MEM)
FBS-supplemented (PM-FBS) PL-Supplemented (PM-PL)
15 % fetal bovin serum (FBS) 5 % platelet lysate (PL)
0.2 mM L-ascorbic acide 2-phosphate (Vit C) 10 U/ml heparin
2 mM L-glutamine 100 U/ml penicillin
100 U/ml penicillin 10 μg/ml streptomycin
10 μg/ml streptomycin
FBS-supplemented (OM-FBS) PL-Supplemented (OM-PL)
15 % fetal bovin serum (FBS) 5 % platelet lysate (PL)
0.2 mM L-ascorbic acide 2-phosphate (Vit C) 0.2 mM L-ascorbic acide 2-phosphate (Vit C)
2 mM L-glutamine 2 mM L-glutamine
100 U/ml penicillin 100 U/ml penicillin
10 μg/ml streptomycin 10 μg/ml streptomycin
10–8 M dexamethasone 10–8 M dexamethasone
0.01 M β-glycerophosphate 0.01 M β-glycerophosphate
0.02 10 U/ml heparin
Table 2 Reagents for scaffold
preparation and cell encapsulation Groups A. Without cells B. With the cells
CaP/Collagen 0:1 (control) Reagents Volume (μL) Reagents Volume (μL)
Collagen 2610 Collagen 2610
PBS(10×) 300 PBS(10×) 300
CaP susp. - CaP susp. -
NaOH 1 N 60 NaOH 1 N 60
H2O/α-MEM 30 H2O/α-MEM 0
Cell susp. – Cell susp. 30
Total 3000 μl Total 3000 μl
CaP/Collagen 1:1 Reagents Volume (μL) Reagents Volume (μL)
Collagen 2610 Collagen 2610
PBS(10×) 240 PBS(10×) 240
CaP susp. 60(150 mg/ml) CaP susp. 60(150 mg/ml)
NaOH 1 N 60 NaOH 1 N 60
H2O/α-MEM 30 H2O/α-MEM 0
Cell susp. – Cell susp. 30
Total 3000 μl Total 3000 μl
CaP/Collagen 2:1 Reagents Volume (μL) Reagents Volume (μL)
Collagen 2610 Collagen 2610
PBS(10×) 180 PBS(10×) 180
CaP susp. 120(150 mg/ml) CaP susp. 120(150 mg/ml)
NaOH 1 N 60 NaOH 1 N 60
H2O/α-MEM 30 H2O/α-MEM
Cell susp. – Cell susp. 30
Total 3000 μl Total 3000 μl
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For the analysis of cellular behavior (DNA content, ALP
activity and calcium [Ca] deposition) and histological analysis
(HE staining, Von Kossa staining and immunohistochemistry
[IHC]) hydrogels were injected in 48 well plates, with the total
hydrogel volume of 200 μl (200.000 cells; n = 3). To obtain
sufficient RNA, hydrogels for RNA extraction were injected
in 24 well plates, with the total volume of 400 μl (400.000
cells; n = 3). All samples were incubated in corresponding
osteogenic media (Table 1), supplemented with either 5 %
PL for AT-MSCs or 15 % FBS for BM-MSCs and incubated
for 35 days at 37 °C in a humid atmosphere with 5 % CO2. To
monitor the behavior of pure hydrogels (without cells) as a
negative control nHA/COL = 0/1, nHA/COL = 1/1, nHA/
COL = 2/1 constructs were prepared and cultured either in
PL or in FBS supplemented media. Cell morphology was
monitored with an inverted light microscope (Leica DM-IL,
5 W LED illumination, Rijswijk, The Netherlands).
Cell Behavior
To monitor cellular behavior, cellular DNA content, alkaline
phosphatase (ALP) activity and calcium deposition were ana-
lyzed [1]. Samples were collected (at days 1, 14, 28 and 35) in
1 ml MilliQ and subsequently stored at −80 °C until use. The
same samples were used for all biochemical assays. For ex-
traction of cells from hydrogels, scaffolds were digested first
using Collagenase A (Roche Diagnostics Penzberg, Germa-
ny). According to the manufacturer’s instruction, a digestion
buffer was prepared in a concentration of 1 mg/ml. Before
digestion, the constructs were washed 2 times with PBS, in-
cubated with 1 ml digestion buffer overnight at 37 °C on a
rotary shaker. After complete digestion and two repetitive
freeze/thaw cycles at -80 °C/+20 °C, samples were ready for
the analysis of DNA content, ALP activity and Ca deposition
[1, 27]. The results of ALP content were normalized by the
corresponding cellular dsDNA amount. After analyzing DNA
content and ALP activity, samples were doubled in volume
using 1 N acetic acid (to dissolve mineral deposits) and
incubated at room temperature overnight. Ca deposition was
measured as described previously [28].
Cellular DNA Content
Cellular DNA content was measured using a QuantiFluor®
dsDNA System Kit (Promega, Madison, Wisconsin, USA).
For the standard curve, serial dilutions of dsDNA stock
(range: 0–2000 ng/ml) were prepared. 100 μl of either sample
of standard solution was added into the wells, followed by
100 μl of working solution. The plate was incubated at room
temperature for 5 min, and then the absorbance of samples/
standards was measured at 504 nm excitation and 541 nm
emission, using a fluorescence microplate reader (FL600,
BioTek, Canada).
Alkaline Phosphatase (ALP) Activity
ALP activity was measured using a 5 nM p-nitrophenyl phos-
phate (4-NP) colorimetric assay. The procedure was according to
the manufacturer’s instruction (Sigma-Aldrich, St. Louis, MO,
USA). Briefly, 80 μl of sample solution was combined with
20μl of buffer (0.5M 2-amino-2methyl-1-propanol). A standard
curve was prepared with serial dilutions of 4-NP, in a range of 0–
25 nmol. Next, 100 μl substrate solution (5 nM p-nitrophenyl
phosphate)was added to the samples/standards and incubated for
60min at 37°C. The reactionwas stopped by adding to eachwell
50μl 0.3MNaOH and the absorbance of samples wasmeasured
at 405 nm using an ELISA microplate reader (EL800, BioTek,
Abcoude, The Netherlands). ALP activity was normalized for
corresponding cellular dsDNA amount.
Calcium Deposition
Ca l c i um depo s i t i o n wa s me a s u r e d u s i n g t h e
orthocresolphtalein complexone assay (OCPC; Sigma Al-
drich, St. Louis, MO, USA), which is based on a colorimetric
reaction between o-cresolphthalein complexone and calcium.
Table 3 Schematic overview of the experimental groups used with varying CaP-particle content (Ca) and with/- cells
Ca=0 Ca=1 Ca=2 Ca=0
+cells
Ca=1
+cells
Ca=2
+cells
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The assay was performed according to the manufacturer’s
instruction. For the standard curve, serial dilutions of calcium
stock (CaCl2) were prepared (range: 0–100 mg/ml). Next,
10 μl of sample or standard was used, to which 300 μl OCPC
solution was added to complete the reaction. After the incu-
bation of the plate for 10 min at room temperature, the absor-
bance was measured at 570 nm using an ELISA microplate
reader (EL800, BioTek, Canada).
RNA Isolation and Reverse Transcription
To analyze gene expression profiles of selected genes, cellular
RNA was isolated using Tryzol method in combination with
the Genelute Mammalian Total RNA Miniprep Kit (Sigma-
Aldrich). Samples were collected (at days 0, 14, 28 and 35) in
1 ml TRIzol lysis buffer and subsequently stored at -80 °C
until RNA extraction. After extraction, RNA was quantified
using a spectrophotometer (Nanodrop Technologies, Wil-
mington, DE, USA). For reverse transcription (cDNA synthe-
sis), an iScript™ cDNA kit was used (Bio-Rad, Hercules, CA,
USA), and for each cDNA reaction 1 μg of RNA was used.
The samples were stored at -20 °C until use.
Real-Time Polymerase Chain Reaction
For real-time polymerase chain reaction (RT-PCR), qPCR
Master Mix Plus/SYBR Green I (Eurogentec; Seraing, Bel-
gium) was used. RT-PCR was completed with 40 amplifica-
tion cycles. The sequence of applied primers is given in Table
4. The raw data were normalized to the expression of Ribo-
somal Protein Large P0 (RPLP0 housekeeping gene) within
the same sample/RNA [29]. Gene expression level and fold
changes were calculated according to Livak & Schmittgen
(2-ΔΔCt) relative subsequently to AT-MSCs or BM-MSCs at
the day 0 [30]. The genes of interest were Osteocalcin (OCN),
Bone Morphogenetic Protein 2 (BMP2), Runt-related Tran-
scription Factor 2 (RUNX2), and Collagen type 1 (COL1).
Histological Analysis and Immunohistochemistry
Samples for histological analysis and IHC were collected at
day 7 and 28, fixed at 10% formalin, decalcified in 4%EDTA
for ~2 weeks, and regularly checked with X-ray for the level
of remaining mineral content in the constructs. After complete
demineralization, samples were dehydrated in a graded series
of ethanol (70–100 %) and embedded in paraffin. Simulta-
neously, human bone chips (obtained from the Department
of Maxillofacial surgery, Radboudumc, Nijmegen,
The Netherlands; after written informed consent), were
processed as a control for all stains. Sections with a
thickness of 6 μm were prepared using a standard mi-
crotome (RM2165; Leica, Nussloch, Germany). To ana-
lyze cell distribution in hydrogels, every 10th slide was
stained with hematoxylin/eosin (HE). To identify phos-
phate groups in mineralized matrix, separate slides were
prepared for Von Kossa staining, which were stained
first with 5 % silver nitrate (AgNO3), washed with dis-
tilled water, dehydrated again, and fixed with 5 % so-
dium thiosulfate (Na2S2O3).
Subsequently, continuous tissue sections were used to
monitor osteogenic differentiation of cells in hydrogels.
As an osteogenic marker, osteocalcin (OCN, rabbit anti-
mouse osteocalcin) protein was cheeked by IHC. Sec-
tions were de-paraffinised, rehydrated and rinsed in
PBS. Next, samples were fixed for 10 min in 10 %
hydrogen peroxide (stock)/methanol solution. After-
wards, samples were pre-incubated for 10 min with
10 % normal donkey serum (NDS) and then incubated
with the primary antibody (1:1600) overnight at 4 °C. Subse-
quently, sections were washed 3× with PBS, and incubated
with secondary antibody, anti mouse IgG (host donkey) con-
jugated with biotin (Jackson ImmunoResearch, West Balti-
more Pike, West Grove, PA, USA) for 60 min. After washing,
the peroxidase conjugates were visualized with 3′3diamino-
benzidine (DAB) substrate (Envision kit; Dako Cytomation)
for 10 min at room temperature, and nuclei were stained for
10 s with hematoxilin.
Statistical Analysis
Data are presented as mean ± standard deviation. Statis-
tical analysis was performed based on N = 3 (for all
experimental groups) with Graphpad Prism® 5.03 soft-
ware (Graphpad Software Inc., San Diego, CA, USA).
Quantitative results were analyzed using a one-way
ANOVA with a Posthoc Dunnett test (using either nHA/
COL = 0/1 or day 7 [for biochemical assays] and day 14
[for Q-PCR analysis] data as control). Differences were con-
sidered significant at p < 0.05. All experiments were repeated
4 times.
Table 4 Primer sequences for RT-PCR
Gene name Sequences
RPLP0 Forward-TTCTTCTTTGGGCTG GTCAT
Reverse-TTGGGTAGCCAATCTGCAGA
RUNX2 Forward-TCTGGCCTTCCACTCTCAGT
Reverse-GACTGGCGGGGTGTAAGTAA
BMP-2 Forward-CCCAGCGTGAAAAGAGAGAC
Reverse-GGAAGCAGCAACGCTAGAAG
COL1 Forward-GGTGTAAGCGGTGGTGGTTAT
Reverse-AGGTTCCCCGTTCTCACTTT
OCN Forward- GGCGCTACCTGTATCAATGG
Reverse-GTGGTCAGCCAACTCGTCA
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Results
The results of FACS analysis showed that both cell
types (AT-MSCs and BM-MSCs) were 99 % positive
for expression of stem cell surface markers CD73,
CD90 and CD105, whereas both these cell types were
completely negative for the hematopoietic marker CD45
(data not shown).
Fig. 1 Cell morphology of AT-
MSCs or BM-MSCs monitored
with inverted light microscopy in
different nHA/COL constructs,
after 3 days of culture
Fig. 2 Cellular behavior of MSCs in different nHA/COL constructs. a
Cellular DNA content of AT-MSCs, b Cellular DNA content BM-MSCs
c ALP-activity of AT-MSCs, (D) ALP-activity of BM-MSCs. The B*^
indicates significantly different compared to nHA/COL = 0/1 control, at
the same time point (p-values: *p < 0.05, **p < 0.01, ***p < 0.001), B#^
indicates significantly different compared to day 7 (p-values: #p < 0.05,
##p < 0.01, ###p < 0.001)
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Cell Morphology
Light microscopy analysis showed that both AT-MSCs and
BM-MSCs were able to survive in nHA/COL constructs
(Fig. 1). Both cell types showed an elongated, spindle-
shaped morphology in these constructs, but from 3 days of
culture onward, AT-MSCs visually appeared at higher cell
density than BM-MSCs. After 7 days, hydrogels changed
their shape and morphology, becoming dense and no longer
transparent for light microscopy evaluation. The constructs
shrunk drastically by changing diameter size about 2-fold
(from ~11 mm to ~4-5 mm).
Cellular Behavior
Cellular DNA Content
AT-MSCs showed a gradual increase in cell proliferation until
day 14 (Fig. 2a). A significant temporal increase in cellular
DNA content (relative to day 7) was observed for AT-nHA/
COL = 0/1 at day 14 (p < 0.05), AT-nHA/COL = 1/1 at day 14,
28, 35 (p < 0.001), and AT-nHA/COL = 2/1 at day 14,
(p < 0.001). Relative to AT-nHA/COL = 0/1, at day 7, a sig-
nificantly lower cellular DNA content was observed for AT-
nHA/COL = 1/1 (p < 0.05) and AT-nHA/COL = 2/1
(p < 0.01).
BM-MSCs (Fig. 2b), showed limited cell proliferation over
the entire culture period. Relative to day 7, a significant in-
crease in cellular DNA content was observed only for BM-
nHA/COL = 2/1 at day 14 (p < 0.05).
ALPActivity
AT-MSCs showed a gradual increase in ALP-activity (early
marker for osteogenic differentiation) until the end of the cul-
ture period, irrespective of construct type (Fig. 2c). A signif-
icant increase in ALP-activity (relative to day 7) was observed
for AT-nHA/COL = 0/1 and AT-nHA/COL = 1/1 at day 28 and
35 (p < 0.001), and AT-nHA/COL = 2/1 at days 28 (p < 0.01)
and 35 (p < 0.001). Relative to AT-nHA/COL = 0/1, no sig-
nificant differences were observed for AT-nHA/COL = 1/1
and AT-nHA/COL = 2/1.
In contrast to AT-MSCs, very low ALP-activity was ob-
served for BM-MSCs (Fig. 2d) over the entire culture period,
which was significantly decreased (relative to day 7) until the
end of culture in all experimental constructs. Relative to BM-
nHA/COL = 0/1, no significant differences were found be-
tween different constructs.
Fig. 3 Ca deposition of MSCs in different nHA/COL constructs. a Ca
deposition of AT-MSCs, b Ca deposition of BM-MSCs c Normailzed Ca
deposition of AT-MSCs, d Normailzed Ca deposition of BM-MSCs. The
B*^ indicates significantly different compared to nHA/COL = 0/1 control,
at the same time point (p-values: *p < 0.05, **p < 0.01, ***p < 0.001),
B#^ indicates significantly different compared to day 7 (p-values:
#p < 0.05, ##p < 0.01, ###p < 0.001)
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Calcium Deposition
Calcium deposition results (Fig. 3a-b) were normalized for
non-cellular constructs, which were treated similarly as cellu-
lar constructs. The mineralization level for both cell types was
generally low. Relative to day 7, AT-MSCs showed a temporal
increase in calcium deposition (Fig. 3c) for AT-nHA/COL = 1/
1 at day 28 (p < 0.05), and at day 35 (p < 0.001) for all
experimental constructs.
BM-MSCs generally showed a decrease in mineralization
(relative to day 7) starting at day 14 until the end of the culture
period (Fig. 3d). Only for BM-HA/COL = 0/1, an increase in
mineralization was observed at day 35 (p < 0.001). Relative to
BM-nHA/COL = 0/1, a significantly increased mineralization
was observed for BM-nHA/COL = 1/1 and BM-nHA/
COL = 2/1 (p < 0.001) at day 7.
Gene Expression
BMP2AT-MSCs showed a gradual increase in BMP2 expres-
sion until day 28, and decrease again until day 35, irrespective
of construct type (Fig. 4a). Relative to day 14, significantly
higher BMP2 expression was observed for AT-nHA/COL = 0/
1 at day 28 (p < 0.01) and 35 (p < 0.05), for AT-nHA/COL = 1/
1 at day 28 (p < 0.001) and 35 (p < 0.05), and for AT-nHA/
COL = 2/1 at day 28 (p < 0.01) and 35 (p < 0.05). Relative to
AT-nHA/COL = 0/1, significantly higher BMP2 expression
was observed for AT-nHA/COL = 1/1 at day 28 (p < 0.05).
BM-MSCs showed a gradual increase in BMP2 expression
until day 28 and thereafter a decrease until day 35 (Fig. 4b) for
BM-nHA/COL = 1/1 and BM-nHA/COL = 2/1. Relative to
day 14, significantly higher BMP2 expression was observed
for BM-nHA/COL = 1/1 and for BM-nHA/COL = 2/1 at day
28 (p < 0.001). Relative to BM-nHA/COL = 0/1, significantly
higher BMP2 expression was observed for BM-nHA/
COL = 1/1 and for BM-nHA/COL = 2/1 at day 28 (p < 0.01).
RUNX2 AT-MSCs showed an upregulation of RUNX2 ex-
pression after day 14, irrespective of construct type (Fig. 4c).
Relative to day 14, significantly higher RUNX2 expression
was observed for AT-nHA/COL = 1/1 at day 28 (p < 0.05) and
for AT-nHA/COL = 2/1 at day 28 (p < 0.01).
BM-MSCs, showed high levels of RUNX2 expression at
day 14 irrespective to construct type, which further increased
only for BM-nHA/COL = 1/1 (Fig. 4d). Relative to day 14,
significantly higher RUNX2 expression was observed for
BM-nHA/COL = 1/1 at day 28 (p < 0.05). Relative to BM-
nHA/COL = 0/1 significantly higher RUNX2 expression was
observed for BM-nHA/COL = 1/1 at day 28 (p < 0.001) and
for BM-nHA/COL = 2/1 at day 14 (p < 0.001).
Fig. 4 Gene expression profiles of BMP2 and RUNX2. a Gene
expression of BMP2 in AT-MSCs, b Gene expression of BMP2 in BM-
MSCs, cGene expression of RUNX2 in AT-MSCs, dGene expression of
RUNX2 in BM-MSCs. The B*^ indicates significantly different
compared to nHA/COL = 0/1 control, at the same time point (p-values:
*p < 0.05, **p < 0.01, ***p < 0.001), B#^ indicates significantly different
compared to day 14 (p-values: #p < 0.05, ##p < 0.01, ###p < 0.001)
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Ocn AT-MSCs showed an upregulation of OCN expression
starting at day 28 until day 35, except for AT-nHA/COL = 2/1,
for which the expression of OCNwas downregulated after day
28 (Fig. 5a). Relative to day 14, significantly higher OCN
expression was observed for AT-nHA/COL = 0/1 at day 28
and 35 (p < 0.001), for AT-nHA/COL = 1/1 at day 28
(p < 0.001) and 35 (p < 0.01), and for AT-nHA/COL = 2/1
at day 28 (p < 0.001). Relative to AT-nHA/COL = 0/1, signif-
icantly higher OCN expression was observed for AT-nHA/
COL = 2/1 at day 35 (p < 0.05).
BM-MSCs, showed high expression of OCN at day 14,
which was downregulated toward the end of the culture peri-
od, irrespective of construct type (Fig. 5b). Relative to day 14,
significantly lower OCN expression was observed for BM-
nHA/COL = 0/1 at day 35 (p < 0.05), for BM-nHA/
COL = 1/1 at day 28 (p < 0.01) and 35 (p < 0.001) and for
BM-nHA/COL = 2/1 at day 28 and 35 (p < 0.05). Relative to
BM-nHA/COL = 0/1, an upregulation of OCN expression
was observed for BM-nHA/COL = 1/1 at day 14 (p < 0.05)
and 28 (p < 0.01).
COL1 AT-MSCs showed an upregulation of COL1 expres-
sion starting at day 28 (Fig. 5c), irrespective of construct type.
Significantly higher COL1 expression (relative to day 14) was
observed for AT-nHA/COL= 0/1 at day 28 and 35 (p < 0.001),
for AT-nHA/COL = 1/1 at day 28 (p < 0.01) and 35
(p < 0.001), and for AT-nHA/COL = 2/1 at day 28
(p < 0.01) and 35 (p < 0.01). Relative to AT-nHA/COL = 0/
1, the expression of COL1 was significantly higher for AT-
nHA/COL = 1/1 at day 35 (p < 0.001) and for AT-nHA/
COL = 2/1 at day 28 and 35 (p < 0.01).
BM-MSCs showed high expression of COL1 at day 14,
after which the COL1 expression was downregulated until
the end of the culture period (Fig. 5d). Relative to day 14,
significantly lower COL1 expression was observed for BM-
HA/COL = 0/1 at day 28 (p < 0.05), for BM-HA/COL = 1/1 at
day 28 and 35 (p < 0.01) and for BM-HA/COL = 2/1 at day 28
and 35 (p < 0.01). Relative to BM-HA/COL = 0/1, significant-
ly higher COL1 expression was for BM-HA/COL = 1/1 at day
14 (p < 0.01) and for BM-HA/COL = 2/1 at day 28 (p < 0.01).
Histological Analysis and Immunohistochemistry
HE StainHE-stained histological sections of all experimental
constructs as well as HE stained sections of human bone (pos-
itive control) are presented in Fig. 6a. Results of AT-MSC
constructs showed that at day 7 as well as at day 28, cells were
distributed throughout the entire construct. At the periphery of
constructs, the cellular density was apparently higher com-
pared to the centre of constructs (high density cell populations
are indicated with arrows in Fig. 6a-1, 2, 3, 5). The distribution
of BM-MSCs in nHA/COL constructs was different at
Fig. 5 Gene expression profiles of OCN and COL1. a Gene expression
of OCN in AT-MSCs, b Gene expression of OCN in BM-MSCs, c Gene
expression of COL1 in AT-MSCs, d Gene expression of COL1 in BM-
MSCs. The B*^ indicates significantly different compared to nHA/
COL = 0/1 control, at the same time point (p-values: *p < 0.05,
**p < 0.01, ***p < 0.001), B#^ indicates significantly different
compared to day 14 (p-values: #p < 0.05, ##p < 0.01, ###p < 0.001)
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different time points. At day 7, cells were homogeneously
distributed throughout the entire construct (Fig. 6a-7, 8, 9).
However, at day 28 cells were mainly located at the periphery
of constructs, and only few cells were detectable in the central
region (Fig. 6a-10, 11, 12).
VonKossa Stain Tomonitor the mineral deposition inside the
constructs, Von Kossa staining was used (Fig. 6b). Mineral
deposition was only detectable for AT-nHA/COL = 1/1 and
AT-nHA/COL = 2/1 at day 28.
IHC-OCN Stain AT-MSCs showed detectable OCN expres-
sion at day 28, especially for AT-nHA/COL = 0/1 (Fig. 7-4, 5,
6). OCN protein was homogeneously distributed throughout
the entire construct. AT-MSCs were observed in these con-
structs with an elongated, spindle-shaped morphology
(highlighted with arrows in Fig. 7-4, 5, 6). BM-MSCs showed
high OCN expression at day 7, especially for BM-nHA/
COL = 1/1 and for BM-nHA/COL = 2/1 (Figs. 7-8, 9). At
day 28, the OCN was still detectable for BM-nHA/COL = 0/1
and BM-nHA/COL = 1/1, but not for BM-nHA/COL = 2/1
(Figs. 7–10, 11, 12).
Discussion & Conclusion
The aim of this study was to comparatively evaluate the in vitro
effect of biomimetic nHA/collagen based composite hydrogels
(with different concentrations of nHA) on the behavior of
MSCs, isolated from adipose tissue (AT-MSCs) and bone mar-
row (BM-MSCs). We hypothesized that (i) nHA/collagen
based hydrogels promote the osteogenic differentiation of
MSCs in nHA concentration dependent manner, and that (ii)
AT-MSCs will show higher osteogenic capacities compared to
BM-MSCs, because of their intrinsic proliferation and osteo-
genic differentiation potential in 2D in vitro cultures. This study
indicated that AT-MSCs show high proliferation, differentiation
and mineralization potential in nHA/COL constructs, irrespec-
tive of nHA concentration, whereas BM-MSCs showed only
marginal cell proliferation and osteogenic differentiation in all
experimental nHA/COL constructs. Based on the results of
ALP activity and OCN protein level, the osteogenic differenti-
ation of BM-MSCs started in the beginning of the culture peri-
od and for AT-MSCs at the end of the culture period. At a
molecular level, both cell types showed high expression of
osteogenic markers (BMP2, RUNX2, OCN or COL1) in both
a nHA concentration and time dependent manner.
Fig. 6 a HA staining of different group of nHA/COL constructs after 7 and 28 days of culture, b Von Kossa staining of different group of nHA/COL
constructs after 28 days of culture
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At a cellular level, the material properties (different nHA/
COL ratio) did not show any substantial effect on the cellular
behavior of AT-MSCs or BM-MSCs. However, apparent dif-
ferences were observed between cell types, i.e. the source for
MSCs. AT-MSCs showed higher proliferation and osteogenic
differentiation compared to BM-MSCs. This phenomenon
corroborates several earlier studies [1, 23], but this study clear-
ly demonstrates that the cellular behavior of AT-MSCs does
not change in a nHA concentration dependent manner. High
proliferation levels of AT-MSCs could potentially provide
faster cell-cell interaction compared to BM-MSCs, and this
cellular interaction in 3D micro-environment could promote
subsequent AT-MSC osteogenic differentiation [23, 31]. Re-
markably, BM-MSCs started to proliferate and differentiate
already within the first week of culture, irrespective of nHA
concentration, whereas AT-MSCs started to differentiate only
after the third week of culture. Early osteogenic differentiation
of BM-MSCs can be explained with faster osteocyte forma-
tion. The signaling mechanisms involved in osteocyte forma-
tion could be activated at different time points in AT-MSCs
and BM-MSCs, because AT-MSCs and BM-MSCs were cul-
tured in different (PL or FBS supplemented) osteogenic media
with different content of signaling molecules [32].
Molecular analysis of osteogenic markers, i.e. BMP2 (os-
teoblast differentiation marker), RUNX2 (essential element
for osteogenic differentiation and skeletal morphogenesis),
OCN (later stage osteogenic differentiation marker) and
COL1 (crucial element of connective tissue) [33–35] showed
that the material properties (nHA concentration) have an effect
on the gene expression pattern of these molecules. It is known
that nHA play a functional role in integrin-mediated cell ad-
hesion and signaling [36]. Cell adhesion to ECM is mediated
Fig. 7 Immunohistochemical staining of OCN, in different group of nHA/COL constructs, after 7 and 28 days of culture
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by transmembrane receptors [37]. This initiates intracellular
signals, and focal adhesion kinase activation [38], which play
a crucial role in activation of downstream signaling. This sig-
naling cascade can stimulate the activation of transcription
factors and subsequent signal transduction [39]. For AT-
MSCs, the expression of BMP2, RUNX2 and COL1 was
promoted by AT-nHA/COL = 1/1 constructs, whereas the ex-
pression of OCN and COL1 was promoted by AT-nHA/
COL = 2/1 constructs.
For BM-MSCs the expression pattern of BMP2, RUNX2,
OCN and COL1 was remarkably higher in BM-nHA/
COL = 1/1 constructs, especially in the beginning of the cul-
ture period (at day 14). This observation proved that the oste-
ogenic differentiation of BM-MSCs starts at an earlier time
points compared to AT-MSCs. Moreover, already at day 7,
BM-MSCs expressed high levels of OCN, which also indi-
cates early osteogenic differentiation of BM-MSCs. Next, AT-
MSCs and BM-MSCs showed a similar pattern of BMP2
expression. It has been shown that AT-MSCs can respond to
BMP2 signals and express other osteogenic markers (e.g.
OPN and RUNX2) [40], which indicates that AT-MSCs are
a reliable cell type for future use in cell-based bone regenera-
tive strategies.
In conclusion, AT-MSCs demonstrated higher osteogenic
potential in nHA/COL based 3D micro-environments com-
pared to BM-MSCs, in which proliferation and osteogenic
differentiation were highly promoted. The proliferation and
osteogenic differentiation pattern of AT-MSCs and BM-
MSCs was regulated in a time dependent manner, irrespective
of nHA amount in the constructs. On the other hand, nHA/
COL ratios differently affected gene expression profiles of
AT-MSCs and BM-MSCs. The fact that AT-MSCs showed
high proliferation and mineralization is appealing for their
application in future (pre-)clinical research as an alternative
cell source for MSCs.
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